Cardiology Round-Up: Icosapent Ethyl, Upper Extremity DVT; and More
Doc Wire News,
The Lifetime Worth of Icosapent Ethyl: A Cost Effective Analysis of REDUCE-IT Cost-effective analysis of the Reduction of…
The Lifetime Worth of Icosapent Ethyl: A Cost Effective Analysis of REDUCE-IT Cost-effective analysis of the Reduction of…
According to a report, published in BMC Surgery, the occurrence of upper extremity deep vein thrombosis (UEDVT) has increased…